Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Mivacurium chloride
Drug ID BADD_D01482
Description Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end-plate to antagonize the action of acetylcholine, resulting in a block of neuromuscular transmission.
Indications and Usage For inpatients and outpatients, as an adjunct to general anesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Marketing Status Prescription; Discontinued
ATC Code M03AC10
DrugBank ID DB01226
KEGG ID D00763
MeSH ID D000077590
PubChem ID 5281080
TTD Drug ID D0OB2M
NDC Product Code 46439-8764
Synonyms Mivacurium | Mivacurium Chloride | BW B1090U | BW-B-1090U | BWB1090U | BW-B1090U | BW-B 1090U | BW B 1090U | BWB 1090U | Mivacron
Chemical Information
Molecular Formula C58H80Cl2N2O14
CAS Registry Number 106861-44-3
SMILES C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC [N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C.[Cl-].[Cl-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic reaction10.01.07.001; 24.06.03.006--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Arrhythmia02.03.02.001--Not Available
Bradycardia02.03.02.002--Not Available
Bronchospasm10.01.03.012; 22.03.01.004--
Dermatitis23.03.04.002--Not Available
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug effect decreased08.06.01.008--Not Available
Drug effect prolonged08.06.01.012--Not Available
Erythema23.03.06.001--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Hypotension24.06.03.002--
Hypoxia22.02.02.003--
Immune system disorder10.02.01.001--Not Available
Injection site reaction12.07.03.015; 08.02.03.014--
Muscle spasms15.05.03.004--
Neuromuscular block prolonged17.05.04.005; 12.02.12.004--Not Available
Phlebitis24.05.03.001; 12.02.01.002--
Rash23.03.13.001--Not Available
Skin disorder23.03.03.007--Not Available
Tachycardia02.03.02.007--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Wheezing22.03.01.009--
Angiopathy24.03.02.007--Not Available
Cardiac disorder02.01.01.003--Not Available
Mediastinal disorder22.09.03.001--Not Available
The 1th Page    1    Total 1 Pages